Ke Tian, Peng-ju Li, Yan Zhang Department of Orthopaedic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, Peopleâs Republic of ChinaCorrespondence: Yan ZhangDepartment of Orthopaedic Surgery, The First Affiliated Hospital of Zhengzhou University, No. 1 East Jianshe Road, District of Erqi, Zhengzhou, 450052, Henan, Peopleâs Republic of China, Tel +86-13783610679, Email zhangyan741101@163.comPurpose: More precise identification of osteosarcoma patients with high early death risk and enhanced early follow-up of these patients, such as increasing the frequency of postoperative chest computed tomography (CT) and local magnetic resonance imaging (MRI) examinations, may improve the overall survival of patients. The primary purpose of this research is to explore the risk factors related to early mortality in patients with osteosarcoma under standard treatment.Patients and Methods: Our research included 87 osteosarcoma patients who had undergone standard treatment and had a Karnofsky (KPS) ⥠70. We define patients who die within 2 years of diagnosis as early death. The clinical characteristics and laboratory indicators of patients with osteosarcoma were collected and analyzed retrospectively.Results: The median follow-up time was 32 months (4â 91 months). Early deaths occurred in 13 patients. Early death of patients with osteosarcoma is related to tumor metastasis (P < 0.001), tumor size > 5cm (P = 0.049), high-level neutrophilâlymphocyte ratio (NLR) (P = 0.035), high-level fibrinogen (FIB) (P = 0.038), and higher D-dimer (DD) (P = 0.025). According to our results of multivariate Cox analysis, tumor metastasis status at diagnosis (P < 0.001), NLR (P = 0.039) and FIB (P = 0.023) are independent risk factors in predicting early mortality in osteosarcoma patients. The âOsteosarcoma Early Mortality Nomogramâ has a C index of 0.871, and the calibration curve performs best compared with the ideal model in predicting mortality in 1 year.Conclusion: Tumor metastasis status, NLR, and FIB are independent risk factors in predicting early mortality in osteosarcoma patients. The early follow-up of patients with tumor metastasis, high NLR, and high FIB should be strengthened.Keywords: osteosarcoma, early death, biomarker, survival